KRS 230.265: Kentucky Equine Drug Research Council.

(1) (a) There is hereby created a panel, to be known as the Kentucky Equine Drug

Research Council, to advise the corporation on the conduct of equine drug

research and testing commissioned by the Kentucky Horse Racing and

Gaming Corporation.

(b) The council shall consist of nine (9) members appointed by the Governor. It is

recommended that the Governor appoint one (1) person from each of the

following groups, organizations, or professions:

1. A veterinarian, selected from a list of three (3) submitted by the

Kentucky Association of Equine Veterinarians;

2. A horseman, selected from a list of three (3) submitted by the Kentucky

division of the Horsemen's Benevolent and Protective Association;

3. A pharmacologist, selected from a list of three (3) submitted by the

University of Kentucky;

4. A Thoroughbred breeder, selected from a list of three (3) submitted by

the Kentucky Thoroughbred Owners and Breeders, Inc.;

5. A legislator, selected from a list of three (3) submitted by the Legislative

Research Commission;

6. A re presentative of a licensed racing association, chosen by the

Governor;

7. A member of the harness racing industry, selected from a list of three (3)

submitted by the chairman of the Kentucky Horse Racing and Gaming

Corporation;

8. A member selected from a list of three (3) submitted by the Kentucky

Harness Horsemen's Association; and

9. A member of the Kentucky Horse Racing and Gaming Corporation,

selected from a list of three (3) submitted by the chairman of the

Kentucky Horse Racing and Gaming Corporation, to serve as chairman.

(c) The council shall meet at the call of the chairman, a majority of the council, or

at the request of the corporation. Members shall serve at the pleasure of their

respective sponsoring organizations and shall receive no compensation for

serving.

(2) The Kentucky Equine Drug Research Council shall:

(a) Review equine drug research and testing research being conducted at the

University of Kentucky, or with state funds;

(b) Review and report to the corporation on drug research and testing research

being conducted elsewhere;

(c) Advise the corporation and ma ke recommendations for establishing an

effective drug regulatory policy for Kentucky racing; and

(d) Report to the General Assembly any needed changes regarding the regulation

of drugs in horse racing in the Commonwealth of Kentucky.

(3) (a) The funds received by the corporation pursuant to KRS 138.510 shall be used

for financing:

1. Drug research;

2. Testing research;

3. Equine medical research;

4. Equine health research issues; and

5. Any regulatory or administrative activity of the corporation that is

related to the research and issues described in subparagraphs 1. to 4. of

this paragraph. Any expenditure under this subsection shall relate to the

racing industry in Kentucky.

(b) In authorizing expenditures, the council and the corporation shall give funding

priority to the activities described in this subsection which will take place, or

are proposed to take place, in Kentucky over similar activities taking place

outside Kentucky. However, expenditures under this subsection in furtherance

of activities taking place outside Kentucky may be approved if the council and

the corporation determine that those expenditures will contribute to

improvement in Kentucky's racing industry and to the development of a useful

knowledge base relating to the subjects express ed in paragraph (a)1. to 5. of

this subsection.

(c) The money received under this subsection shall be in addition to any funds

appropriated to the corporation for these purposes in the executive budget.